Cutting-edge science for healthcare

We are an important partner to the Slovenian healthcare system with our generic and biosimilar medicines.

Read key business and development news in our company and various activities that we support and co-create. You can also browse the news archives dating back to 1998, our photo library and visual identity. For additional information, you can write to us at info.lek@sandoz.com.

Press releases
15. 5. 2024

Lek, a Sandoz company, was awarded the  "Family Friendly Company" certificate by the Institute for Labor and  the Ministry of Labor. This is an acknowledgement ...

14. 5. 2024

From May 9 to 10, Lek hosted TechBEAT, offering promising secondary school students from Slovenia a unique insight into the challenges and trends in the ...

19. 4. 2024

Today, Sandoz celebrated the start of construction of its state-of-the-art Biosimilars Development Center inLjubljana. Dignitaries including Prime Minister Dr Robert Golob, complimented Sandoz's commitment ...

4. 4. 2024

Lek, a Sandoz company, has been awarded the title of Most Reputable Employer 2023, presented by the job portal Mojedelo.com since 2007.

Contact

Lek d.d.
Verovškova 57, 1526 Ljubljana, Slovenia
T: +386 1 580 21 11
F: +386 1 568 35 17
info.lek@sandoz.com
VAT No.: SI87916452
Registration number: 1732811000
Nominal capital: 48.402.003,00 EUR

Video library